Effect of short course high dose methylprednisolone on endothelin-1 and nitric oxide in children with acute lymphoblastic leukemia: A preliminary study

Annals of Hematology

Volumn 85, Issue 1, 2006, Pages 55-57

  Ozyurek, Emel ^a,b   Okur, Hamza ^a   Gurgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

ALL; Endothelin 1; High dose methylprednisolone; Nitric oxide

Indexed keywords

ENDOTHELIN 1; METHYLPREDNISOLONE; NITRIC OXIDE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MEGADOSE; ENDOTHELIUM LESION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; METHYLPREDNISOLONE; NITRIC OXIDE;

EID: 28944453084     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-0016-x     Document Type: Article

References (11)

1. Lee AYY, Levine MN (1999) The thrombotic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 25:137-145 10357081
2. Öner AF, Gürgey A, Kirazli S, Okur H, Tunc B (1999) Changes of haemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methyl prednisolone and L-asparaginase. Leuk Lymphoma 33:361-364 10221516
3. Nowak-Gottl U, Wermes C, Junker R, Koch H-G, Schobess R, Fleischback G, Schwabe D, Ehrenforth S (1999) Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 93:1595-1599 10029588
4. Unal S, Varan A, Yalcin B, Buyukpamukcu M, Gurgey A (2005) Evaluation of thrombotic children with malignancy. Ann Hematol 84:395-399 10.1007/ s00277-005-1004-x
5. Pui CH, Jackson CW, Chesney CM, Abildgaard CF (1987) Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. Am J Hematol 25:291-298 3111251
6. Gross PL, Aird WC (2000) The endothelium and thrombosis. Semin Thromb Hemost 26:463-478 10.1055/s-2000-13202
7. Yetgin S, Tuncer MD, Cetin M, Gumruk F, Yenicesu Ý, Tunc B, Oner AO, Toksoy H, Koc A, Aslan D, Ozyurek E, Olcay L, Atahan L, Tuncbilek E, Gurgey A (2003) Benefit of high dose methylprednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up. Leukemia 17:328-333 10.1038/sj.leu.2402673
8. 15N]nitrate in biological fluids. Annal Biochem 126:131-138 10.1016/0003-2697(82)90118-X
9. Morin C, Asselin C, Boudreau F, Provencher PH (1998) Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun 244:583-587 10.1006/ bbrc.1998.8300
10. Dinkel K, MacPherson A, Sapolsky RM (2003) Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 84:705-716 10.1046/ j.1471-4159.2003.01604.x
11. Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A (2000) Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells. J Allergy Clin Immunol 105:333-338 10.1016/S0091-6749(00)90084-8